Despite the prominent role for tissue factor (TF)in various physiological processes, primarily in those relatedto blood coagulation, there is a lack of information with respect to the structure and function of natural TFforms existing in vivo. Most experimental data related to TF have been derived using various forms ofrecombinant proteins. Our preliminary data indicate that monocytic TF present on the native membrane is150-400-fold more active than any TF, recombinant or natural, presented on an artificial membrane. Theprimary goal of this proposal is to study natural human TF from multiple sources by evaluating their structuraland functional properties and by identifying the cell membrane component(s) responsible for high TF activity.Substantial amounts of placental, monocyte and mtcroparticle TF proteins will be purified by immunoaffinitymethods. Characterization of purified TF species will utilize immunoassays, structural, biochemical andfunctional assays as well as structure-function analyses. Functional characterization of TF proteins bothpurified and presented on native membranes will include factor Vila-driven reactions in one enzyme-onesubstrate systems (fluorogenic assays, extrinsic factor Xase and factor IX activation) followed by morecomplex systems, such as TF-initiated thrombin generation in synthetic coagulation proteome and wholeblood. The posttranslational modifications of the purified TF species will be characterized usingdeglycosylation, tryptic digestion, mass-spectroscopy and sequencing. The influence of these modificationson TF activity will be analyzed. Purified human TF from placenta will be used as a standard in allevaluations, functional and structural. Three different species of recombinant human TF will be used forcomparison as well, i.e. TF^ea (full-length), TFi_242 (lacking the cytoplasmic domain), and TFi.2is (soluble;extracellular domain only). We will also attempt to understand the mechanism underlying high monocyte TFin situ activity by purifying, analyzing and evaluating the component(s) of the monocyte membrane, lipid raftsand monocyte-derived microparticles. The data accumulated during this study will expand our knowledgerelated to the structural and functional properties of natural human TF. New knowledge linking TF structureand environment with functional activity will be obtained.Relevance: This project will lead to a better understanding of the mechanisms regulating the activity of tissuefactor, a key protein in the initiation of blood clotting and an emerging link between inflammation andthrombosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL046703-16A1
Application #
7328147
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-07-01
Budget End
2008-07-31
Support Year
16
Fiscal Year
2007
Total Cost
$234,056
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Kusak, Piotr; Czarnecka, Danuta; Gissel, Matthew et al. (2016) Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic stroke. Arch Med Sci 12:1000-1007
Bouchard, Beth A; Chapin, John; Brummel-Ziedins, Kathleen E et al. (2015) Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency. Blood 125:3647-50
Brummel-Ziedins, Kathleen E; Everse, Stephen J; Mann, Kenneth G et al. (2014) Modeling thrombin generation: plasma composition based approach. J Thromb Thrombolysis 37:32-44
Bouchard, Beth A; Gissel, Matthew T; Whelihan, Matthew F et al. (2014) Platelets do not express the oxidized or reduced forms of tissue factor. Biochim Biophys Acta 1840:1188-93
de Haan, Hugoline G; Bezemer, Irene D; Vossen, Carla Y et al. (2014) Genetic variants in Cell Adhesion Molecule 1 (CADM1): a validation study of a novel endothelial cell venous thrombosis risk factor. Thromb Res 134:1186-92
Undas, A; Brummel-Ziedins, K E; Mann, K G (2014) Anticoagulant effects of statins and their clinical implications. Thromb Haemost 111:392-400
Whelihan, Matthew F; Kiankhooy, Armin; Brummel-Ziedins, Kathleen E (2014) Thrombin generation and fibrin clot formation under hypothermic conditions: an in vitro evaluation of tissue factor initiated whole blood coagulation. J Crit Care 29:24-30
Krudysz-Amblo, Jolanta; Jennings 2nd, Mark E; Knight, Tyler et al. (2013) Disulfide reduction abolishes tissue factor cofactor function. Biochim Biophys Acta 1830:3489-96
Ayombil, F; Abdalla, S; Tracy, P B et al. (2013) Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool. J Thromb Haemost 11:1532-9
Baker, Jason V; Brummel-Ziedins, Kathleen; Neuhaus, Jacqueline et al. (2013) HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc 2:e000264

Showing the most recent 10 out of 247 publications